IMS Health, Quintiles Announce All-stock Merger Of Equals - Quick Facts

(RTTNews) - IMS Health Holdings, Inc. (IMS) and Quintiles Transnational Holdings Inc. (Q) announced their boards approved a merger agreement, pursuant to which the companies will be combined in an all-stock merger of equals transaction. The merged company will be named Quintiles IMS Holdings, Inc. The equity market capitalization of the joined companies is more than $17.6 billion and the enterprise value is more than $23 billion.

IMS Health shareholders will receive a fixed exchange ratio of 0.384 shares of Quintiles common stock for each share of IMS Health common stock. Upon completion of the merger, IMS Health shareholders will own approximately 51.4 percent of the shares of the combined company on a fully diluted basis and Quintiles shareholders will own approximately 48.6 percent of the combined company on a fully diluted basis.

Ari Bousbib, chairman and CEO of IMS Health, will become chairman and CEO of the merged organization. Tom Pike, chief executive officer of Quintiles, will become vice chairman.

The companies expect the deal to accelerate revenue growth, adding an anticipated 100 - 200 basis points to the combined annual growth rate by the end of year three; and accretive to adjusted EPS in 2017.